nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Faeces discoloured—Octreotide—thymus cancer	0.061	0.061	CcSEcCtD
Esomeprazole—Goitre—Octreotide—thymus cancer	0.0296	0.0296	CcSEcCtD
Esomeprazole—Hypochromic anaemia—Octreotide—thymus cancer	0.0273	0.0273	CcSEcCtD
Esomeprazole—Ulcerative stomatitis—Octreotide—thymus cancer	0.0229	0.0229	CcSEcCtD
Esomeprazole—Hernia—Octreotide—thymus cancer	0.0226	0.0226	CcSEcCtD
Esomeprazole—Epigastric pain—Octreotide—thymus cancer	0.0219	0.0219	CcSEcCtD
Esomeprazole—Rectal disorder—Octreotide—thymus cancer	0.0216	0.0216	CcSEcCtD
Esomeprazole—Anorectal disorder—Octreotide—thymus cancer	0.0201	0.0201	CcSEcCtD
Esomeprazole—Anorectal discomfort—Octreotide—thymus cancer	0.0193	0.0193	CcSEcCtD
Esomeprazole—Multiple fractures—Octreotide—thymus cancer	0.0182	0.0182	CcSEcCtD
Esomeprazole—Fracture—Octreotide—thymus cancer	0.0182	0.0182	CcSEcCtD
Esomeprazole—Menstrual disorder—Octreotide—thymus cancer	0.0155	0.0155	CcSEcCtD
Esomeprazole—Otitis media—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Esomeprazole—Petechiae—Octreotide—thymus cancer	0.0129	0.0129	CcSEcCtD
Esomeprazole—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Esomeprazole—Arthropathy—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Esomeprazole—Vaginal inflammation—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Esomeprazole—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Esomeprazole—Injection site reaction—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Esomeprazole—Eructation—Octreotide—thymus cancer	0.0104	0.0104	CcSEcCtD
Esomeprazole—Cystitis noninfective—Octreotide—thymus cancer	0.0103	0.0103	CcSEcCtD
Esomeprazole—Cystitis—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Esomeprazole—Candida infection—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Esomeprazole—Vaginal infection—Octreotide—thymus cancer	0.00999	0.00999	CcSEcCtD
Esomeprazole—Urine output increased—Octreotide—thymus cancer	0.00956	0.00956	CcSEcCtD
Esomeprazole—Bladder pain—Octreotide—thymus cancer	0.00956	0.00956	CcSEcCtD
Esomeprazole—Mouth ulceration—Octreotide—thymus cancer	0.00956	0.00956	CcSEcCtD
Esomeprazole—Gynaecomastia—Octreotide—thymus cancer	0.00946	0.00946	CcSEcCtD
Esomeprazole—Sleep disorder—Octreotide—thymus cancer	0.00887	0.00887	CcSEcCtD
Esomeprazole—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00883	0.00883	CcSEcCtD
Esomeprazole—Polyuria—Octreotide—thymus cancer	0.00874	0.00874	CcSEcCtD
Esomeprazole—Gastroenteritis—Octreotide—thymus cancer	0.00866	0.00866	CcSEcCtD
Esomeprazole—Injury—Octreotide—thymus cancer	0.00835	0.00835	CcSEcCtD
Esomeprazole—Hot flush—Octreotide—thymus cancer	0.00821	0.00821	CcSEcCtD
Esomeprazole—Menopausal symptoms—Octreotide—thymus cancer	0.00814	0.00814	CcSEcCtD
Esomeprazole—Visual disturbance—Octreotide—thymus cancer	0.0081	0.0081	CcSEcCtD
Esomeprazole—Arthritis—Octreotide—thymus cancer	0.0079	0.0079	CcSEcCtD
Esomeprazole—Hypoglycaemia—Octreotide—thymus cancer	0.00787	0.00787	CcSEcCtD
Esomeprazole—Osteoarthritis—Octreotide—thymus cancer	0.00768	0.00768	CcSEcCtD
Esomeprazole—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00768	0.00768	CcSEcCtD
Esomeprazole—Pain in extremity—Octreotide—thymus cancer	0.00768	0.00768	CcSEcCtD
Esomeprazole—Irritability—Octreotide—thymus cancer	0.00733	0.00733	CcSEcCtD
Esomeprazole—Dry skin—Octreotide—thymus cancer	0.00704	0.00704	CcSEcCtD
Esomeprazole—Abdominal pain upper—Octreotide—thymus cancer	0.00701	0.00701	CcSEcCtD
Esomeprazole—Cramp muscle—Octreotide—thymus cancer	0.00691	0.00691	CcSEcCtD
Esomeprazole—Gastritis—Octreotide—thymus cancer	0.00679	0.00679	CcSEcCtD
Esomeprazole—Muscular weakness—Octreotide—thymus cancer	0.00677	0.00677	CcSEcCtD
Esomeprazole—Abdominal distension—Octreotide—thymus cancer	0.00668	0.00668	CcSEcCtD
Esomeprazole—Asthma—Octreotide—thymus cancer	0.00664	0.00664	CcSEcCtD
Esomeprazole—Influenza—Octreotide—thymus cancer	0.00664	0.00664	CcSEcCtD
Esomeprazole—Bronchospasm—Octreotide—thymus cancer	0.00653	0.00653	CcSEcCtD
Esomeprazole—Pancreatitis—Octreotide—thymus cancer	0.00651	0.00651	CcSEcCtD
Esomeprazole—Sweating increased—Octreotide—thymus cancer	0.00646	0.00646	CcSEcCtD
Esomeprazole—Dysuria—Octreotide—thymus cancer	0.0062	0.0062	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Octreotide—thymus cancer	0.00617	0.00617	CcSEcCtD
Esomeprazole—Pollakiuria—Octreotide—thymus cancer	0.00613	0.00613	CcSEcCtD
Esomeprazole—Weight increased—Octreotide—thymus cancer	0.00604	0.00604	CcSEcCtD
Esomeprazole—Weight decreased—Octreotide—thymus cancer	0.006	0.006	CcSEcCtD
Esomeprazole—Depression—Octreotide—thymus cancer	0.0059	0.0059	CcSEcCtD
Esomeprazole—Jaundice—Octreotide—thymus cancer	0.00577	0.00577	CcSEcCtD
Esomeprazole—Urinary tract infection—Octreotide—thymus cancer	0.00575	0.00575	CcSEcCtD
Esomeprazole—Conjunctivitis—Octreotide—thymus cancer	0.00575	0.00575	CcSEcCtD
Esomeprazole—Haematuria—Octreotide—thymus cancer	0.00564	0.00564	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Octreotide—thymus cancer	0.0056	0.0056	CcSEcCtD
Esomeprazole—Epistaxis—Octreotide—thymus cancer	0.00558	0.00558	CcSEcCtD
Esomeprazole—Sinusitis—Octreotide—thymus cancer	0.00555	0.00555	CcSEcCtD
Esomeprazole—Bradycardia—Octreotide—thymus cancer	0.00541	0.00541	CcSEcCtD
Esomeprazole—Rhinitis—Octreotide—thymus cancer	0.00532	0.00532	CcSEcCtD
Esomeprazole—Hepatitis—Octreotide—thymus cancer	0.00531	0.00531	CcSEcCtD
Esomeprazole—Hypoaesthesia—Octreotide—thymus cancer	0.00528	0.00528	CcSEcCtD
Esomeprazole—Pharyngitis—Octreotide—thymus cancer	0.00527	0.00527	CcSEcCtD
Esomeprazole—Oedema peripheral—Octreotide—thymus cancer	0.00523	0.00523	CcSEcCtD
Esomeprazole—Visual impairment—Octreotide—thymus cancer	0.00512	0.00512	CcSEcCtD
Esomeprazole—Tinnitus—Octreotide—thymus cancer	0.00495	0.00495	CcSEcCtD
Esomeprazole—Flushing—Octreotide—thymus cancer	0.00493	0.00493	CcSEcCtD
Esomeprazole—Immune system disorder—Octreotide—thymus cancer	0.0048	0.0048	CcSEcCtD
Esomeprazole—Alopecia—Octreotide—thymus cancer	0.00469	0.00469	CcSEcCtD
Esomeprazole—Mental disorder—Octreotide—thymus cancer	0.00465	0.00465	CcSEcCtD
Esomeprazole—Malnutrition—Octreotide—thymus cancer	0.00462	0.00462	CcSEcCtD
Esomeprazole—Flatulence—Octreotide—thymus cancer	0.00456	0.00456	CcSEcCtD
Esomeprazole—Tension—Octreotide—thymus cancer	0.00454	0.00454	CcSEcCtD
Esomeprazole—Nervousness—Octreotide—thymus cancer	0.00449	0.00449	CcSEcCtD
Esomeprazole—Back pain—Octreotide—thymus cancer	0.00447	0.00447	CcSEcCtD
Esomeprazole—Muscle spasms—Octreotide—thymus cancer	0.00445	0.00445	CcSEcCtD
Esomeprazole—Vision blurred—Octreotide—thymus cancer	0.00436	0.00436	CcSEcCtD
Esomeprazole—Tremor—Octreotide—thymus cancer	0.00433	0.00433	CcSEcCtD
Esomeprazole—Ill-defined disorder—Octreotide—thymus cancer	0.00429	0.00429	CcSEcCtD
Esomeprazole—Anaemia—Octreotide—thymus cancer	0.00427	0.00427	CcSEcCtD
Esomeprazole—Agitation—Octreotide—thymus cancer	0.00425	0.00425	CcSEcCtD
Esomeprazole—Malaise—Octreotide—thymus cancer	0.00417	0.00417	CcSEcCtD
Esomeprazole—Vertigo—Octreotide—thymus cancer	0.00415	0.00415	CcSEcCtD
Esomeprazole—Palpitations—Octreotide—thymus cancer	0.00409	0.00409	CcSEcCtD
Esomeprazole—Cough—Octreotide—thymus cancer	0.00403	0.00403	CcSEcCtD
Esomeprazole—Hypertension—Octreotide—thymus cancer	0.00399	0.00399	CcSEcCtD
Esomeprazole—Arthralgia—Octreotide—thymus cancer	0.00394	0.00394	CcSEcCtD
Esomeprazole—Chest pain—Octreotide—thymus cancer	0.00394	0.00394	CcSEcCtD
Esomeprazole—Myalgia—Octreotide—thymus cancer	0.00394	0.00394	CcSEcCtD
Esomeprazole—Anxiety—Octreotide—thymus cancer	0.00392	0.00392	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00391	0.00391	CcSEcCtD
Esomeprazole—Discomfort—Octreotide—thymus cancer	0.00389	0.00389	CcSEcCtD
Esomeprazole—Dry mouth—Octreotide—thymus cancer	0.00385	0.00385	CcSEcCtD
Esomeprazole—Anaphylactic shock—Octreotide—thymus cancer	0.00377	0.00377	CcSEcCtD
Esomeprazole—Infection—Octreotide—thymus cancer	0.00375	0.00375	CcSEcCtD
Esomeprazole—Shock—Octreotide—thymus cancer	0.00371	0.00371	CcSEcCtD
Esomeprazole—Nervous system disorder—Octreotide—thymus cancer	0.0037	0.0037	CcSEcCtD
Esomeprazole—Thrombocytopenia—Octreotide—thymus cancer	0.00369	0.00369	CcSEcCtD
Esomeprazole—Tachycardia—Octreotide—thymus cancer	0.00368	0.00368	CcSEcCtD
Esomeprazole—Skin disorder—Octreotide—thymus cancer	0.00367	0.00367	CcSEcCtD
Esomeprazole—Hyperhidrosis—Octreotide—thymus cancer	0.00365	0.00365	CcSEcCtD
Esomeprazole—Anorexia—Octreotide—thymus cancer	0.0036	0.0036	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00344	0.00344	CcSEcCtD
Esomeprazole—Insomnia—Octreotide—thymus cancer	0.00341	0.00341	CcSEcCtD
Esomeprazole—Paraesthesia—Octreotide—thymus cancer	0.00339	0.00339	CcSEcCtD
Esomeprazole—Dyspnoea—Octreotide—thymus cancer	0.00336	0.00336	CcSEcCtD
Esomeprazole—Somnolence—Octreotide—thymus cancer	0.00335	0.00335	CcSEcCtD
Esomeprazole—Dyspepsia—Octreotide—thymus cancer	0.00332	0.00332	CcSEcCtD
Esomeprazole—Decreased appetite—Octreotide—thymus cancer	0.00328	0.00328	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Octreotide—thymus cancer	0.00326	0.00326	CcSEcCtD
Esomeprazole—Fatigue—Octreotide—thymus cancer	0.00325	0.00325	CcSEcCtD
Esomeprazole—Pain—Octreotide—thymus cancer	0.00323	0.00323	CcSEcCtD
Esomeprazole—Constipation—Octreotide—thymus cancer	0.00323	0.00323	CcSEcCtD
Esomeprazole—Feeling abnormal—Octreotide—thymus cancer	0.00311	0.00311	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Octreotide—thymus cancer	0.00309	0.00309	CcSEcCtD
Esomeprazole—Urticaria—Octreotide—thymus cancer	0.003	0.003	CcSEcCtD
Esomeprazole—Abdominal pain—Octreotide—thymus cancer	0.00298	0.00298	CcSEcCtD
Esomeprazole—Body temperature increased—Octreotide—thymus cancer	0.00298	0.00298	CcSEcCtD
Esomeprazole—Hypersensitivity—Octreotide—thymus cancer	0.00278	0.00278	CcSEcCtD
Esomeprazole—Asthenia—Octreotide—thymus cancer	0.00271	0.00271	CcSEcCtD
Esomeprazole—Pruritus—Octreotide—thymus cancer	0.00267	0.00267	CcSEcCtD
Esomeprazole—Diarrhoea—Octreotide—thymus cancer	0.00258	0.00258	CcSEcCtD
Esomeprazole—Dizziness—Octreotide—thymus cancer	0.0025	0.0025	CcSEcCtD
Esomeprazole—Vomiting—Octreotide—thymus cancer	0.0024	0.0024	CcSEcCtD
Esomeprazole—Rash—Octreotide—thymus cancer	0.00238	0.00238	CcSEcCtD
Esomeprazole—Dermatitis—Octreotide—thymus cancer	0.00238	0.00238	CcSEcCtD
Esomeprazole—Headache—Octreotide—thymus cancer	0.00236	0.00236	CcSEcCtD
Esomeprazole—Nausea—Octreotide—thymus cancer	0.00224	0.00224	CcSEcCtD
